Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center study.

Mingxia JiangJiaxuan LiuMaiyue HeMengqi ZhangShihan ZhouShanshan ChenRuigang CaiHongnan MoBo LanPin ZhangBinghe XuQiao Li

Published in: Therapeutic advances in medical oncology (2024)

Inetetamab-based combination therapy shows promising efficacy and good safety in patients with HER2-positive ABC. It is one of the late-line treatment options for Chinese patients with HER2-positive ABC.

Keyphrases

combination therapy
stem cells